Structure

Physi-Chem Properties

Molecular Weight:  741.34
Volume:  758.083
LogP:  4.778
LogD:  3.567
LogS:  -4.446
# Rotatable Bonds:  9
TPSA:  201.26
# H-Bond Aceptor:  14
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.14
Synthetic Accessibility Score:  4.993
Fsp3:  0.35
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.558
MDCK Permeability:  8.042370609473437e-06
Pgp-inhibitor:  0.997
Pgp-substrate:  0.996
Human Intestinal Absorption (HIA):  0.022
20% Bioavailability (F20%):  0.874
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.012
Plasma Protein Binding (PPB):  95.9684829711914%
Volume Distribution (VD):  0.213
Pgp-substrate:  2.6894733905792236%

ADMET: Metabolism

CYP1A2-inhibitor:  0.004
CYP1A2-substrate:  0.009
CYP2C19-inhibitor:  0.322
CYP2C19-substrate:  0.045
CYP2C9-inhibitor:  0.623
CYP2C9-substrate:  0.09
CYP2D6-inhibitor:  0.015
CYP2D6-substrate:  0.18
CYP3A4-inhibitor:  0.879
CYP3A4-substrate:  0.064

ADMET: Excretion

Clearance (CL):  5.075
Half-life (T1/2):  0.226

ADMET: Toxicity

hERG Blockers:  0.362
Human Hepatotoxicity (H-HT):  0.98
Drug-inuced Liver Injury (DILI):  0.739
AMES Toxicity:  0.02
Rat Oral Acute Toxicity:  0.109
Maximum Recommended Daily Dose:  0.568
Skin Sensitization:  0.054
Carcinogencity:  0.016
Eye Corrosion:  0.003
Eye Irritation:  0.004
Respiratory Toxicity:  0.051

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC56635

Natural Product ID:  NPC56635
Common Name*:   Paecilodepsipeptide A
IUPAC Name:   (3R,6R,9R,15S,18S)-18-benzyl-9-[(4-hydroxyphenyl)methyl]-6,15-dimethyl-3-[[4-(3-methylbut-2-enoxy)phenyl]methyl]-1-oxa-4,7,10,13,16-pentazacyclooctadecane-2,5,8,11,14,17-hexone
Synonyms:  
Standard InCHIKey:  JNXJCUUDHZAFNN-ZIWQVPDVSA-N
Standard InCHI:  InChI=1S/C40H47N5O9/c1-24(2)18-19-53-31-16-12-29(13-17-31)21-33-40(52)54-34(22-27-8-6-5-7-9-27)39(51)43-25(3)36(48)41-23-35(47)44-32(20-28-10-14-30(46)15-11-28)38(50)42-26(4)37(49)45-33/h5-18,25-26,32-34,46H,19-23H2,1-4H3,(H,41,48)(H,42,50)(H,43,51)(H,44,47)(H,45,49)/t25-,26+,32+,33+,34-/m0/s1
SMILES:  CC(=CCOc1ccc(cc1)C[C@H]1N=C(O)[C@@H](C)N=C(O)[C@@H](Cc2ccc(cc2)O)N=C(O)CN=C([C@@H](N=C([C@@H](OC1=O)Cc1ccccc1)O)C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL224345
PubChem CID:   16216414
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0001813] Peptidomimetics
        • [CHEMONTID:0001961] Depsipeptides
          • [CHEMONTID:0001994] Cyclic depsipeptides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32982 paecilomyces cinnamomeus Species n.a. Eukaryota n.a. n.a. n.a. PMID[17269825]
NPO32716 conoideocrella tenuis bcc 18627 Species Clavicipitaceae Eukaryota n.a. n.a. n.a. PMID[21473608]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 5900.0 nM PMID[484764]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 4900.0 nM PMID[484764]
NPT27 Others Unspecified IC50 = 6600.0 nM PMID[484764]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 = 4900.0 nM PMID[484765]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC56635 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.869 High Similarity NPC6570
0.8611 High Similarity NPC470392
0.8609 High Similarity NPC132771
0.8483 Intermediate Similarity NPC244866
0.8414 Intermediate Similarity NPC45191
0.8344 Intermediate Similarity NPC207675
0.8344 Intermediate Similarity NPC212699
0.8247 Intermediate Similarity NPC245974
0.8235 Intermediate Similarity NPC247298
0.8221 Intermediate Similarity NPC196091
0.8204 Intermediate Similarity NPC32064
0.814 Intermediate Similarity NPC64140
0.814 Intermediate Similarity NPC174122
0.8118 Intermediate Similarity NPC315542
0.8092 Intermediate Similarity NPC473407
0.8092 Intermediate Similarity NPC91953
0.8092 Intermediate Similarity NPC473378
0.8081 Intermediate Similarity NPC234069
0.8072 Intermediate Similarity NPC164608
0.807 Intermediate Similarity NPC276120
0.8026 Intermediate Similarity NPC197921
0.8012 Intermediate Similarity NPC138083
0.7974 Intermediate Similarity NPC212850
0.7974 Intermediate Similarity NPC83289
0.7974 Intermediate Similarity NPC189724
0.7974 Intermediate Similarity NPC469360
0.7959 Intermediate Similarity NPC296712
0.7949 Intermediate Similarity NPC313414
0.7939 Intermediate Similarity NPC186617
0.7919 Intermediate Similarity NPC326966
0.7905 Intermediate Similarity NPC325651
0.7892 Intermediate Similarity NPC471568
0.7892 Intermediate Similarity NPC473693
0.7877 Intermediate Similarity NPC4974
0.7867 Intermediate Similarity NPC471953
0.7857 Intermediate Similarity NPC26108
0.7829 Intermediate Similarity NPC29531
0.7821 Intermediate Similarity NPC50548
0.7808 Intermediate Similarity NPC476260
0.7808 Intermediate Similarity NPC476241
0.78 Intermediate Similarity NPC275538
0.7784 Intermediate Similarity NPC269383
0.7784 Intermediate Similarity NPC151030
0.7778 Intermediate Similarity NPC305700
0.7778 Intermediate Similarity NPC140915
0.7778 Intermediate Similarity NPC197741
0.7778 Intermediate Similarity NPC187028
0.7778 Intermediate Similarity NPC10221
0.7778 Intermediate Similarity NPC18249
0.7771 Intermediate Similarity NPC473502
0.7765 Intermediate Similarity NPC144314
0.7758 Intermediate Similarity NPC472923
0.7755 Intermediate Similarity NPC476179
0.7755 Intermediate Similarity NPC476125
0.7751 Intermediate Similarity NPC155506
0.7751 Intermediate Similarity NPC473354
0.7751 Intermediate Similarity NPC159767
0.775 Intermediate Similarity NPC182119
0.7746 Intermediate Similarity NPC294951
0.7738 Intermediate Similarity NPC89831
0.7736 Intermediate Similarity NPC115144
0.7736 Intermediate Similarity NPC277857
0.7722 Intermediate Similarity NPC5462
0.7719 Intermediate Similarity NPC45037
0.7711 Intermediate Similarity NPC50380
0.7711 Intermediate Similarity NPC254700
0.7711 Intermediate Similarity NPC179250
0.7709 Intermediate Similarity NPC149962
0.7708 Intermediate Similarity NPC319950
0.7707 Intermediate Similarity NPC178466
0.7707 Intermediate Similarity NPC63628
0.7692 Intermediate Similarity NPC248670
0.7692 Intermediate Similarity NPC273755
0.7688 Intermediate Similarity NPC471526
0.7677 Intermediate Similarity NPC318984
0.7677 Intermediate Similarity NPC259800
0.7677 Intermediate Similarity NPC241086
0.7677 Intermediate Similarity NPC317741
0.7677 Intermediate Similarity NPC282087
0.7677 Intermediate Similarity NPC328137
0.7677 Intermediate Similarity NPC318028
0.7655 Intermediate Similarity NPC476183
0.7655 Intermediate Similarity NPC263835
0.7651 Intermediate Similarity NPC210950
0.7651 Intermediate Similarity NPC63931
0.7651 Intermediate Similarity NPC199738
0.7643 Intermediate Similarity NPC222039
0.7643 Intermediate Similarity NPC100478
0.7633 Intermediate Similarity NPC230611
0.7622 Intermediate Similarity NPC287757
0.7622 Intermediate Similarity NPC319320
0.7603 Intermediate Similarity NPC476184
0.7603 Intermediate Similarity NPC476281
0.7602 Intermediate Similarity NPC50016
0.7597 Intermediate Similarity NPC6913
0.7588 Intermediate Similarity NPC137627
0.7588 Intermediate Similarity NPC306804
0.7588 Intermediate Similarity NPC49315
0.7582 Intermediate Similarity NPC123859
0.7578 Intermediate Similarity NPC233702
0.7578 Intermediate Similarity NPC471032
0.7578 Intermediate Similarity NPC470935
0.7572 Intermediate Similarity NPC263507
0.7572 Intermediate Similarity NPC271958
0.7572 Intermediate Similarity NPC134413
0.7572 Intermediate Similarity NPC45112
0.7568 Intermediate Similarity NPC211218
0.7566 Intermediate Similarity NPC114102
0.7564 Intermediate Similarity NPC299583
0.7564 Intermediate Similarity NPC197239
0.7564 Intermediate Similarity NPC326860
0.756 Intermediate Similarity NPC107938
0.756 Intermediate Similarity NPC294516
0.7556 Intermediate Similarity NPC471563
0.7551 Intermediate Similarity NPC142577
0.7551 Intermediate Similarity NPC27581
0.7551 Intermediate Similarity NPC474862
0.755 Intermediate Similarity NPC478147
0.7544 Intermediate Similarity NPC279871
0.7544 Intermediate Similarity NPC473402
0.7544 Intermediate Similarity NPC471165
0.7543 Intermediate Similarity NPC471050
0.7543 Intermediate Similarity NPC471049
0.7543 Intermediate Similarity NPC471048
0.7541 Intermediate Similarity NPC242728
0.7533 Intermediate Similarity NPC476353
0.7531 Intermediate Similarity NPC114659
0.7531 Intermediate Similarity NPC139699
0.7529 Intermediate Similarity NPC476321
0.7528 Intermediate Similarity NPC473305
0.7528 Intermediate Similarity NPC163961
0.7517 Intermediate Similarity NPC95733
0.7517 Intermediate Similarity NPC62101
0.7517 Intermediate Similarity NPC237420
0.7516 Intermediate Similarity NPC274732
0.7514 Intermediate Similarity NPC475421
0.75 Intermediate Similarity NPC241354
0.75 Intermediate Similarity NPC17760
0.75 Intermediate Similarity NPC204848
0.75 Intermediate Similarity NPC41473
0.75 Intermediate Similarity NPC476278
0.75 Intermediate Similarity NPC160607
0.75 Intermediate Similarity NPC312770
0.75 Intermediate Similarity NPC14600
0.7484 Intermediate Similarity NPC81026
0.7471 Intermediate Similarity NPC90984
0.7471 Intermediate Similarity NPC40234
0.7469 Intermediate Similarity NPC153644
0.7468 Intermediate Similarity NPC66518
0.7467 Intermediate Similarity NPC29477
0.7466 Intermediate Similarity NPC43275
0.7442 Intermediate Similarity NPC476227
0.7442 Intermediate Similarity NPC227778
0.7442 Intermediate Similarity NPC158277
0.744 Intermediate Similarity NPC223207
0.744 Intermediate Similarity NPC158900
0.7439 Intermediate Similarity NPC127402
0.7432 Intermediate Similarity NPC160493
0.7431 Intermediate Similarity NPC51345
0.7421 Intermediate Similarity NPC266741
0.7416 Intermediate Similarity NPC94862
0.7414 Intermediate Similarity NPC269750
0.7414 Intermediate Similarity NPC194671
0.7403 Intermediate Similarity NPC214869
0.7396 Intermediate Similarity NPC304074
0.7396 Intermediate Similarity NPC471771
0.7396 Intermediate Similarity NPC290755
0.7391 Intermediate Similarity NPC9373
0.7391 Intermediate Similarity NPC160378
0.7389 Intermediate Similarity NPC471201
0.7386 Intermediate Similarity NPC470112
0.7386 Intermediate Similarity NPC167763
0.7386 Intermediate Similarity NPC35961
0.7386 Intermediate Similarity NPC86678
0.7386 Intermediate Similarity NPC195749
0.7386 Intermediate Similarity NPC470903
0.7386 Intermediate Similarity NPC52029
0.7378 Intermediate Similarity NPC478189
0.7368 Intermediate Similarity NPC251571
0.7366 Intermediate Similarity NPC311357
0.7365 Intermediate Similarity NPC83279
0.7355 Intermediate Similarity NPC169766
0.7329 Intermediate Similarity NPC311737
0.7329 Intermediate Similarity NPC16188
0.7329 Intermediate Similarity NPC169328
0.7329 Intermediate Similarity NPC38458
0.732 Intermediate Similarity NPC155838
0.7312 Intermediate Similarity NPC106183
0.731 Intermediate Similarity NPC317254
0.7308 Intermediate Similarity NPC475468
0.7305 Intermediate Similarity NPC107602
0.7303 Intermediate Similarity NPC299806
0.7301 Intermediate Similarity NPC324081
0.7297 Intermediate Similarity NPC190663
0.7293 Intermediate Similarity NPC477526
0.729 Intermediate Similarity NPC307123
0.729 Intermediate Similarity NPC97870
0.729 Intermediate Similarity NPC247018
0.7288 Intermediate Similarity NPC469831
0.7285 Intermediate Similarity NPC47667

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC56635 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8776 High Similarity NPD7596 Clinical (unspecified phase)
0.8447 Intermediate Similarity NPD7608 Discontinued
0.8125 Intermediate Similarity NPD7972 Discontinued
0.8089 Intermediate Similarity NPD7131 Phase 3
0.8025 Intermediate Similarity NPD6390 Discontinued
0.795 Intermediate Similarity NPD8019 Approved
0.7871 Intermediate Similarity NPD2976 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD6502 Phase 2
0.78 Intermediate Similarity NPD6798 Discontinued
0.7792 Intermediate Similarity NPD7450 Phase 2
0.7748 Intermediate Similarity NPD6233 Phase 2
0.7748 Intermediate Similarity NPD7477 Discontinued
0.7748 Intermediate Similarity NPD5729 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD3536 Discontinued
0.7697 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.7677 Intermediate Similarity NPD1538 Phase 1
0.7677 Intermediate Similarity NPD2239 Approved
0.7677 Intermediate Similarity NPD2240 Approved
0.7677 Intermediate Similarity NPD1519 Approved
0.7677 Intermediate Similarity NPD1537 Approved
0.7632 Intermediate Similarity NPD5745 Approved
0.7628 Intermediate Similarity NPD7978 Discontinued
0.7616 Intermediate Similarity NPD3136 Phase 2
0.7578 Intermediate Similarity NPD4186 Clinical (unspecified phase)
0.7572 Intermediate Similarity NPD7959 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD6582 Phase 2
0.7568 Intermediate Similarity NPD6583 Phase 3
0.7564 Intermediate Similarity NPD1523 Approved
0.7564 Intermediate Similarity NPD1522 Approved
0.7561 Intermediate Similarity NPD6677 Suspended
0.756 Intermediate Similarity NPD6746 Phase 2
0.7548 Intermediate Similarity NPD1536 Approved
0.7546 Intermediate Similarity NPD3455 Phase 2
0.7545 Intermediate Similarity NPD8070 Approved
0.7529 Intermediate Similarity NPD8014 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6867 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6866 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5746 Approved
0.7455 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD1048 Approved
0.745 Intermediate Similarity NPD3676 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD8031 Discontinued
0.7436 Intermediate Similarity NPD1520 Approved
0.7436 Intermediate Similarity NPD1521 Approved
0.7434 Intermediate Similarity NPD2614 Approved
0.7419 Intermediate Similarity NPD6355 Discontinued
0.7417 Intermediate Similarity NPD6584 Phase 3
0.7417 Intermediate Similarity NPD7451 Discontinued
0.7412 Intermediate Similarity NPD7484 Phase 3
0.7412 Intermediate Similarity NPD7485 Phase 3
0.741 Intermediate Similarity NPD5356 Approved
0.741 Intermediate Similarity NPD5355 Approved
0.7407 Intermediate Similarity NPD5348 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD5865 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4062 Phase 3
0.74 Intermediate Similarity NPD196 Phase 1
0.7383 Intermediate Similarity NPD5108 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD3400 Discontinued
0.7372 Intermediate Similarity NPD3052 Approved
0.7372 Intermediate Similarity NPD3054 Approved
0.7371 Intermediate Similarity NPD6211 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD3823 Discontinued
0.7368 Intermediate Similarity NPD7315 Approved
0.7356 Intermediate Similarity NPD3965 Phase 1
0.7349 Intermediate Similarity NPD2541 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD3274 Phase 2
0.7349 Intermediate Similarity NPD6072 Discontinued
0.7342 Intermediate Similarity NPD6032 Approved
0.7325 Intermediate Similarity NPD5688 Approved
0.7325 Intermediate Similarity NPD5689 Approved
0.7314 Intermediate Similarity NPD5557 Phase 1
0.7305 Intermediate Similarity NPD4433 Discontinued
0.7305 Intermediate Similarity NPD7495 Discontinued
0.7305 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD6556 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD3909 Discontinued
0.7297 Intermediate Similarity NPD7565 Approved
0.7296 Intermediate Similarity NPD3656 Approved
0.729 Intermediate Similarity NPD1423 Approved
0.7273 Intermediate Similarity NPD4003 Phase 3
0.7267 Intermediate Similarity NPD6331 Phase 2
0.7267 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD5563 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD3465 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD4993 Discontinued
0.725 Intermediate Similarity NPD2897 Discontinued
0.725 Intermediate Similarity NPD7153 Discontinued
0.7239 Intermediate Similarity NPD6682 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD4477 Approved
0.7233 Intermediate Similarity NPD4476 Approved
0.7232 Intermediate Similarity NPD7039 Approved
0.7232 Intermediate Similarity NPD7038 Approved
0.723 Intermediate Similarity NPD6830 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD3374 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD3056 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD3685 Discontinued
0.7212 Intermediate Similarity NPD7427 Discontinued
0.7204 Intermediate Similarity NPD7811 Phase 3
0.7204 Intermediate Similarity NPD7810 Phase 3
0.7202 Intermediate Similarity NPD4018 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD4622 Approved
0.7197 Intermediate Similarity NPD555 Phase 2
0.7197 Intermediate Similarity NPD4618 Approved
0.7195 Intermediate Similarity NPD4123 Phase 3
0.7195 Intermediate Similarity NPD3985 Discontinued
0.7195 Intermediate Similarity NPD7446 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD4739 Approved
0.7184 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD5822 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD6666 Approved
0.7178 Intermediate Similarity NPD6667 Approved
0.7176 Intermediate Similarity NPD7773 Phase 2
0.7167 Intermediate Similarity NPD6967 Phase 2
0.7162 Intermediate Similarity NPD6581 Approved
0.7162 Intermediate Similarity NPD6580 Approved
0.7162 Intermediate Similarity NPD1894 Discontinued
0.7161 Intermediate Similarity NPD7095 Approved
0.7161 Intermediate Similarity NPD5163 Phase 2
0.716 Intermediate Similarity NPD5773 Approved
0.716 Intermediate Similarity NPD5772 Approved
0.7152 Intermediate Similarity NPD52 Approved
0.7152 Intermediate Similarity NPD7526 Approved
0.7152 Intermediate Similarity NPD7527 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD4666 Phase 3
0.7135 Intermediate Similarity NPD8005 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD3847 Discontinued
0.7126 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD7318 Phase 3
0.7115 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD7523 Phase 3
0.7107 Intermediate Similarity NPD7097 Phase 1
0.7099 Intermediate Similarity NPD2459 Approved
0.7099 Intermediate Similarity NPD2458 Approved
0.7099 Intermediate Similarity NPD2460 Phase 3
0.7095 Intermediate Similarity NPD7132 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD5709 Phase 3
0.7093 Intermediate Similarity NPD6315 Phase 2
0.7086 Intermediate Similarity NPD1535 Discovery
0.7081 Intermediate Similarity NPD6312 Discontinued
0.707 Intermediate Similarity NPD259 Phase 1
0.707 Intermediate Similarity NPD2674 Phase 3
0.7056 Intermediate Similarity NPD7546 Discontinued
0.7055 Intermediate Similarity NPD4110 Phase 3
0.7055 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD4628 Phase 3
0.7048 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD3778 Approved
0.7041 Intermediate Similarity NPD6386 Approved
0.7041 Intermediate Similarity NPD6385 Approved
0.7039 Intermediate Similarity NPD1481 Phase 2
0.7035 Intermediate Similarity NPD6971 Discontinued
0.703 Intermediate Similarity NPD7212 Phase 2
0.703 Intermediate Similarity NPD7213 Phase 3
0.7027 Intermediate Similarity NPD9568 Approved
0.7025 Intermediate Similarity NPD826 Approved
0.7025 Intermediate Similarity NPD825 Approved
0.7024 Intermediate Similarity NPD5811 Approved
0.7019 Intermediate Similarity NPD2161 Phase 2
0.7019 Intermediate Similarity NPD3175 Clinical (unspecified phase)
0.7017 Intermediate Similarity NPD6853 Approved
0.7017 Intermediate Similarity NPD6851 Approved
0.7006 Intermediate Similarity NPD6620 Discovery
0.7 Intermediate Similarity NPD7577 Discontinued
0.7 Intermediate Similarity NPD7317 Phase 3
0.6994 Remote Similarity NPD8245 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6862 Phase 2
0.6994 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6988 Remote Similarity NPD7447 Phase 1
0.6986 Remote Similarity NPD821 Approved
0.6986 Remote Similarity NPD7843 Approved
0.6986 Remote Similarity NPD5535 Approved
0.6983 Remote Similarity NPD7007 Discovery
0.6982 Remote Similarity NPD4675 Approved
0.6982 Remote Similarity NPD4678 Approved
0.6973 Remote Similarity NPD3819 Phase 2
0.6964 Remote Similarity NPD3686 Approved
0.6964 Remote Similarity NPD3687 Approved
0.6962 Remote Similarity NPD7265 Discontinued
0.6959 Remote Similarity NPD7046 Clinical (unspecified phase)
0.6959 Remote Similarity NPD8455 Phase 2
0.6957 Remote Similarity NPD7861 Discontinued
0.6948 Remote Similarity NPD7258 Clinical (unspecified phase)
0.6943 Remote Similarity NPD4738 Phase 2
0.6941 Remote Similarity NPD7438 Suspended
0.6941 Remote Similarity NPD7118 Clinical (unspecified phase)
0.6937 Remote Similarity NPD4579 Clinical (unspecified phase)
0.6935 Remote Similarity NPD4466 Phase 1
0.6933 Remote Similarity NPD1759 Phase 1
0.6933 Remote Similarity NPD3655 Clinical (unspecified phase)
0.6933 Remote Similarity NPD4534 Discontinued
0.6933 Remote Similarity NPD2030 Discontinued
0.6918 Remote Similarity NPD4060 Phase 1
0.6918 Remote Similarity NPD6346 Approved
0.6913 Remote Similarity NPD3596 Phase 2
0.691 Remote Similarity NPD7493 Clinical (unspecified phase)
0.6909 Remote Similarity NPD5241 Discontinued
0.6909 Remote Similarity NPD3692 Discontinued
0.6903 Remote Similarity NPD1820 Approved
0.6903 Remote Similarity NPD1817 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data